ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Internal Medicine

Top Internal Medicine Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARK OCHENRIDER MD

Internal Medicine

1,266

$63.8K

67
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $56

TODD GOTTSCHALK DO

Internal Medicine

1,280

$66.2K

182
109 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

DAVID BROWN M.D.

Internal Medicine

1,298

$53.9K

237
181 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $56

KENDRA GIL M.D.

Internal Medicine

1,300

$82.7K

145
139 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $56

FREDRIC JACKSON MD PS

Internal Medicine

1,311

$188K

182
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 23%

$143
Average prescription price

Avg: $56

MADHAVI MANDALA MD

Internal Medicine

1,321

$47.8K

191
160 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$36
Average prescription price

Avg: $56

BRITT ANDERSON MD

Internal Medicine

1,325

$72.1K

179
135 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $56

ALEXANDER DUDETSKY MD, PH.,D.

Internal Medicine

1,326

$87.8K

45
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $56

LISA HAMILL MD

Internal Medicine

1,328

$68.6K

182
148 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

HASSAN HADDADIN M.D

Internal Medicine

1,332

$281K

207
167 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

80%
prescriptions for brand name drugs

Avg: 23%

$211
Average prescription price

Avg: $56

SIMONA MARIE MD

Internal Medicine

1,344

$98.7K

130
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$73
Average prescription price

Avg: $56

REENA ESHWAR MD MSPH

Internal Medicine

1,348

$49K

132
123 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$36
Average prescription price

Avg: $56

WAYNE LIN M.D.

Internal Medicine

1,360

$268K

312
255 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$197
Average prescription price

Avg: $56

DANIEL FRANK MD

Internal Medicine

1,362

$123K

73
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 23%

$90
Average prescription price

Avg: $56

COURTNEY NEVITT M.D.

Internal Medicine

1,365

$35K

99
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$26
Average prescription price

Avg: $56

JOHN SYPE M.D.

Internal Medicine

1,365

$41.5K

220
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 23%

$30
Average prescription price

Avg: $56

MEREDITH HEICK MD

Internal Medicine

1,373

$141K

123
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$103
Average prescription price

Avg: $56

LISA CHEW

Internal Medicine

1,381

$54.1K

78
31 are 65+

41%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 23%

$39
Average prescription price

Avg: $56

JOHN CHOE M.D., M.P.H.

Internal Medicine

1,382

$63.2K

53
20 are 65+

38%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

DARSHANA SHANBHAG M.D.

Internal Medicine

1,383

$82.7K

134
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $56

RICHARD LYNN M.D.

Internal Medicine

1,399

$84.2K

290
271 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $56

MADHURINA ROY MD

Internal Medicine

1,404

$71.8K

62
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

35%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $56

LEAH INMAN D.O.

Internal Medicine

1,443

$87.4K

218
147 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $56

ANITA UPPAL M.D.

Internal Medicine

1,446

$97.4K

165
148 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$67
Average prescription price

Avg: $56

SUJATA POISSON M.D.

Internal Medicine

1,451

$398K

118
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$274
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank